首页> 外文期刊>Journal of environmental biology >Establishing the botanical identity of plant drugs based on their active ingredients under diverse growth conditions
【24h】

Establishing the botanical identity of plant drugs based on their active ingredients under diverse growth conditions

机译:在多种生长条件下,根据其活性成分确定植物药的植物学特征

获取原文
获取原文并翻译 | 示例
           

摘要

Higher plants are the major source of crude drugs used in herbal therapy. Adulteration in crude drug material has necessitated scientific characterization of plant drugs, which is based primarily on morphological, anatomical and physico-chemical characters studied through microscopy and some analytical techniques. These criteria are helpful in isolating the adulterants from the actual drug, but fail to deliver when the very botanical identity of a plant drug is controversial, and several different plant species are used under a single drug name. This article suggests how to face this situation and overcome the problems likely to occur. Quantification of active ingredients in plant tissues is the only dependable way to identify the actual drug out of the different species in use. However, the amount of active ingredients in plants, responsible for the therapeutic efficacy of those plants, may vary with plant genotype and the habitat ecology, regulated largely by soil characters and agro-climatic conditions. Even within the individual plant, concentration of active ingredients often varies with plant parts/organs, stage of plant development and status of plant nutrition. Besides, degradation of environment may not only affect the quantity, but even the composition of the secondary metabolites produced. This situation may alter the chemical properties, and hence the degree of therapeutic effectiveness of these bioactive compounds. Thus, a careful estimation of active ingredients, taking all the above-said situations into account, may decide which species should be regarded as the actual drug, which as an alternative drug and which as the non-drug (if the amount of the ingredient in question is just negligible). It may also indicate which plant organ should preferably be used and what should be the proper stage for harvesting. Further, environmental degradation may have a far-reaching influence on the therapeutic potential of medicinal plants and may also necessitate a re-fixing of drug doses, keeping in view the overall impact of environmental degradation on the active ingredients of these plants on one hand, and on the resistance level/immune system of human beings on the other.
机译:高等植物是草药治疗中使用的原始药物的主要来源。原料药中的掺假必须对植物药进行科学表征,这主要基于通过显微镜和某些分析技术研究的形态,解剖学和物理化学特征。这些标准有助于将掺假物与实际药物隔离开来,但是当植物药的植物学特征引起争议时,并且在单一药物名称下使用几种不同的植物物种时,这些标准将无法实现。本文建议如何面对这种情况并克服可能出现的问题。定量植物组织中的活性成分是从使用中的不同物种中鉴定出实际药物的唯一可靠方法。然而,负责这些植物治疗功效的植物中活性成分的量可能会随植物基因型和栖息地生态而变化,很大程度上受土壤特性和农业气候条件的调节。即使在单个植物中,活性成分的浓度也经常随植物部位/器官,植物发育阶段和植物营养状况而变化。此外,环境的退化不仅会影响其数量,甚至会影响所产生的次级代谢产物的组成。这种情况可能会改变化学性质,从而改变这些生物活性化合物的治疗效果。因此,在考虑所有上述情况的情况下,仔细评估活性成分可以决定应将哪种物种视为实际药物,将哪种物种视为替代药物以及将哪种物种视为非药物(如果成分含量较高)问题只是微不足道的)。它还可能指示应优先使用哪种植物器官,什么才是收获的适当阶段。此外,环境退化可能会对药用植物的治疗潜力产生深远影响,并且还可能需要重新确定药物剂量,一方面要考虑到环境退化对这些植物的活性成分的总体影响,另一方面是人类的抵抗力/免疫系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号